MOLECULAR CANCER THERAPEUTICS
期刊信息导读
- MOLECULAR CANCER THERAPEUTICS基本信息
- MOLECULAR CANCER THERAPEUTICS中科院SCI期刊分区
- 历年MOLECULAR CANCER THERAPEUTICS影响因子趋势图
- MOLECULAR CANCER THERAPEUTICS期刊英文简介
- MOLECULAR CANCER THERAPEUTICS期刊中文简介
MOLECULAR CANCER THERAPEUTICS基本信息
简称:MOL CANCER THER
中文名称:分子癌症疗法
研究方向:医学
2018-2019最新影响因子:4.856
2022年6月28日更新影响因子:6.009
SCI类别:SCIE
是否OA开放访问:No
出版地:UNITED STATES
出版周期:Monthly
创刊年份:2001
年文章数:256
涉及的研究方向:医学-肿瘤学
通讯方式:AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
官方网站:http://mct.aacrjournals.org/
投稿网址:http://mct.msubmit.net/cgi-bin/main.plex
审稿速度:平均3月
平均录用比例:约50%
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1535-7163%5BISSN%5D
MOLECULAR CANCER THERAPEUTICS期刊英文简介
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.
MOLECULAR CANCER THERAPEUTICS期刊中文简介
分子癌症治疗学将侧重于在以下领域对癌症治疗具有意义的基础研究:实验癌症治疗学、分子靶点的识别、化学预防靶点、新模型、癌症化学和药物发现、分子和细胞药理学、肿瘤分子分类、生物信息学和计算分子生物学。该杂志为这些新兴学科提供了一个专门关注癌症研究的出版论坛。论文经过严格审查,只有那些报告新颖、及时、有意义的研究结果并符合高科学价值标准的论文才会被接受发表。
中科院SCI期刊分区:
MOLECULAR CANCER THERAPEUTICS影响因子
获取相关优质资源获取2023中科院分区